Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business
Anupam Nagar

REVEALED: Bayer raises 2026 profit outlook on strong pharmaceuticals performance - The Real Truth

German pharmaceuticals and agriculture group Bayer on Tuesday raised its 2026 profit outlook, citing stronger-than-expected performance in its pharmaceuticals business, which delivered sales above market estimates in the third quarter, Reuters reported.

The company now expects adjusted core earnings, on a currency-adjusted basis, to reach between 9.8 billion euros and 10.3 billion euros in 2026. This compares with its previous forecast of 9.6 billion euros to 10.1 billion euros.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.